Citation: Wz. Zhong et al., SPECIES-DEPENDENT ENANTIOSELECTIVE PHARMACOKINETICS OF PNU-103017, A PYRONE HIV PROTEASE INHIBITOR, Chirality, 10(3), 1998, pp. 210-216
Citation: Gl. Kearns et al., CEFPODOXIME PHARMACOKINETICS IN CHILDREN - EFFECT OF FOOD, The Pediatric infectious disease journal, 17(9), 1998, pp. 799-804
Authors:
BORIN MT
CHAMBERS JH
CAREL BJ
FREIMUTH WW
AKSENTIJEVICH S
PIERGIES AA
Citation: Mt. Borin et al., PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFABUTIN AND DELAVIRDINE MESYLATE IN HIV-1-INFECTED PATIENTS, Antiviral research, 35(1), 1997, pp. 53-63
Authors:
BORIN MT
COX SR
HERMAN BD
CAREL BJ
ANDERSON RD
FREIMUTH WW
Citation: Mt. Borin et al., EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1892-1897
Citation: Mt. Borin et al., PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFAMPIN AND DELAVIRDINE MESYLATE, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 544-553
Authors:
BORIN MT
MCCORMICK DP
SCHWARTZ RH
RYAN KK
Citation: Mt. Borin et al., MIDDLE-EAR FLUID (MEF) LEVELS OF CEFPODOXIME IN PEDIATRIC-PATIENTS WITH ACUTE OTITIS-MEDIA (AOM), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 45-45
Authors:
MORSE GD
FISCHL MA
SHELTON MJ
BORIN MT
DRIVER MR
DEREMER M
LEE K
WAJSZCZUK CP
Citation: Gd. Morse et al., DIDANOSINE REDUCES ATEVIRDINE ABSORPTION IN SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 767-771
Citation: Mt. Borin et al., ABSORPTION OF CLINDAMYCIN AFTER INTRAVAGINAL APPLICATION OF CLINDAMYCIN PHOSPHATE 2-PERCENT CREAM, Journal of antimicrobial chemotherapy, 35(6), 1995, pp. 833-841
Citation: Mt. Borin et al., THE BIOAVAILABILITY OF CEFPODOXIME PROXETIL TABLETS RELATIVE TO AN ORAL SOLUTION, Biopharmaceutics & drug disposition, 16(4), 1995, pp. 295-302
Citation: Mt. Borin et Kk. Forbes, EFFECT OF FOOD ON ABSORPTION OF CEFPODOXIME PROXETIL ORAL SUSPENSION IN ADULTS, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 273-275
Authors:
BORIN MT
DONALDSON KM
HARRY JD
ENOS T
BURTON NK
PULLEN DJ
Citation: Mt. Borin et al., SINGLE-DOSE PHARMACOKINETICS (PK), SAFETY, AND TOLERANCE OF U-96988, A HIV PROTEASE INHIBITOR, IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 143-143
Citation: Mt. Borin et al., PHARMACOKINETICS OF CEFPODOXIME PROXETIL IN HEALTHY-YOUNG AND ELDERLYVOLUNTEERS, Journal of clinical pharmacology, 34(7), 1994, pp. 774-781
Authors:
BORIN MT
DRIVER MR
WAJSZCZUK CP
ANDERSON RD
Citation: Mt. Borin et al., THE EFFECT OF FLUCONAZOLE (FLU) ON THE PHARMACOKINETICS OF ATEVIRDINEMESYLATE (ATV) IN HIV+ PATIENTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 193-193
Citation: Mt. Borin et al., EFFECTS OF FOOD AND ANTACID ON BIOAVAILABILITY OF ATEVIRDINE MESYLATE(ATV) IN HIV+ PATIENTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 194-194
Authors:
JOHNSON CA
ATESHKADI A
ZIMMERMAN SW
HUGHES GS
CRAIG WA
CAREY PM
BORIN MT
Citation: Ca. Johnson et al., PHARMACOKINETICS AND EX-VIVO SUSCEPTIBILITY OF CEFPODOXIME PROXETIL IN PATIENTS RECEIVING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Antimicrobial agents and chemotherapy, 37(12), 1993, pp. 2650-2655